{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T00:18:25Z","timestamp":1715905105854},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,4]]},"DOI":"10.7759\/cureus.20938","type":"journal-article","created":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:02:07Z","timestamp":1641340927000},"source":"Crossref","is-referenced-by-count":2,"title":["Case Report of Acute Pancreatitis Associated With Combination Treatment of Dulaglutide and Glipizide"],"prefix":"10.7759","author":[{"given":"Oyedotun","family":"Babajide","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabin","family":"K C","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaac","family":"Solaimanzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zewge","family":"Shiferaw-Deribe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Pancreatitis","author":"Vege SS","year":"2007","unstructured":"Vege SS, Yadav D, Chari ST. Pancreatitis. GI Epidemiology. Talley NJ, Locke GR, Saito YA (ed): Blackwell Publishing, Malden, MA; 2007. 221-5."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.03.065","article-title":"AGA Institute technical review on acute pancreatitis","volume":"132","author":"Forsmark CE","year":"2007","unstructured":"Forsmark CE, Baillie J. AGA Institute technical review on acute pancreatitis. Gastroenterology. 2007, 132:2022-44. 10.1053\/j.gastro.2007.03.065","journal-title":"Gastroenterology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.6.649","article-title":"Epidemiology of alcohol-related liver and pancreatic disease in the United States","volume":"168","author":"Yang AL","year":"2008","unstructured":"Yang AL, Vadhavkar S, Singh G, Omary MB. Epidemiology of alcohol-related liver and pancreatic disease in the United States. Arch Intern Med. 2008, 168:649-56. 10.1001\/archinte.168.6.649","journal-title":"Arch Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/gut.37.4.565","article-title":"Drug induced acute pancreatitis: incidence and severity","volume":"37","author":"Lankisch PG","year":"1995","unstructured":"Lankisch PG, Dr\u00f6ge M, Gottesleben F. Drug induced acute pancreatitis: incidence and severity. Gut. 1995, 37:565-7. 10.1136\/gut.37.4.565","journal-title":"Gut"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-0842","article-title":"Acute pancreatitis in association with type 2 diabetes and antidiabetic drugs","volume":"33","author":"Gonzalez-Perez A","year":"2010","unstructured":"Gonzalez-Perez A, Schlienger RG, Rodr\u00edguez LAG. Acute pancreatitis in association with type 2 diabetes and antidiabetic drugs. Diabetes Care. 2010, 33:2580-5. 10.2337\/dc10-0842","journal-title":"Diabetes Care"},{"key":"ref6","article-title":"Dulaglutide (Trulicity): the third once-weekly GLP-1 agonist","volume":"41","author":"Smith LL","year":"2016","unstructured":"Smith LL, Mosley JF 2nd, Parke C, Brown J, Barris LS, Phan LD. Dulaglutide (Trulicity): the third once-weekly GLP-1 agonist. P T. 2016, 41:357-60.","journal-title":"P T"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-2761","article-title":"Efficacy and safety of dulaglutide versus sitagliptin after 52 weeks in type 2 diabetes in a randomized controlled trial (AWARD-5)","volume":"37","author":"Nauck M","year":"2014","unstructured":"Nauck M, Weinstock RS, Umpierrez GE, Guerci B, Skrivanek Z, Milicevic Z. Efficacy and safety of dulaglutide versus sitagliptin after 52 weeks in type 2 diabetes in a randomized controlled trial (AWARD-5). Diabetes Care. 2014, 37:2149-58. 10.2337\/dc13-2761","journal-title":"Diabetes Care"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1997.00440290014001","article-title":"Pharmacological regulation of blood glucose levels in non-insulin-dependent diabetes mellitus","volume":"157","author":"Bressler R","year":"1997","unstructured":"Bressler R, Johnson DG. Pharmacological regulation of blood glucose levels in non-insulin-dependent diabetes mellitus. Arch Intern Med. 1997, 157:836-48. 10.1001\/archinte.1997.00440290014001","journal-title":"Arch Intern Med"},{"key":"ref9","unstructured":"ClinCalc DrugStats Database. Free U.S. outpatient drug usage statistics. (2021). Accessed. November 29, 2021: https:\/\/clincalc.com\/DrugStats\/."},{"key":"ref10","article-title":"Trulicity (dulaglutide): a new GLP-1 receptor agonist once-weekly subcutaneous injection approved for the treatment of patients with type 2 diabetes","volume":"8","author":"Fala L","year":"2015","unstructured":"Fala L. Trulicity (dulaglutide): a new GLP-1 receptor agonist once-weekly subcutaneous injection approved for the treatment of patients with type 2 diabetes. Am Health Drug Benefits. 2015, 8:131-4.","journal-title":"Am Health Drug Benefits"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g2366","article-title":"Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies","volume":"348","author":"Li L","year":"2014","unstructured":"Li L, Shen J, Bala MM, et al.. Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies. BMJ. 2014, 348:g2366. 10.1136\/bmj.g2366","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.02.018","article-title":"Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies","volume":"141","author":"Elashoff M","year":"2011","unstructured":"Elashoff M, Matveyenko AV, Gier B, Elashoff R, Butler PC. Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies. Gastroenterology. 2011, 141:150-6. 10.1053\/j.gastro.2011.02.018","journal-title":"Gastroenterology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3770","article-title":"Anti-diabetic therapies and the risk of acute pancreatitis: a nationwide retrospective cohort study from Taiwan","volume":"24","author":"Chang HY","year":"2015","unstructured":"Chang HY, Hsieh CF, Singh S, Tang W, Chiang YT, Huang WF. Anti-diabetic therapies and the risk of acute pancreatitis: a nationwide retrospective cohort study from Taiwan. Pharmacoepidemiol Drug Saf. 2015, 24:567-75. 10.1002\/pds.3770","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/79731-case-report-of-acute-pancreatitis-associated-with-combination-treatment-of-dulaglutide-and-glipizide","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:03Z","timestamp":1707507303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/79731-case-report-of-acute-pancreatitis-associated-with-combination-treatment-of-dulaglutide-and-glipizide"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,4]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.20938","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,4]]}}}